Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib
Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new version entry v3.4.2 was added to the record history, and the previous entry v3.4.1 was removed.SummaryDifference0.1%

- Check20 days agoChange DetectedThe history shows an internal release update with the addition of revision v3.4.1 and removal of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary toggle and color-coded highlights for changes (green for additions, red for deletions) on the history view. A new Revision: v3.4.0 label appears, and the No FEAR Act data entry is removed.SummaryDifference1%

- Check42 days agoChange DetectedThe history now shows a new revision entry v3.3.4 and the previous revision v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe record history now includes a new site release note 'Revision: v3.3.3' and removes the earlier release note 'Revision: v3.3.2' as well as the 'HHS Vulnerability Disclosure' entry from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedA new revision entry v3.3.2 was added and the old v3.2.0 entry was removed from the record history. This is a minor update to the study record page.SummaryDifference0.1%

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib
Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.